These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8740124)

  • 41. Histopathology and immunophenotype of acrodermatitis chronica atrophicans correlated with ospA and ospC genotypes of Borrelia species.
    Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
    J Cutan Pathol; 2015 Oct; 42(10):674-92. PubMed ID: 26156537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field.
    Hu CM; Wilske B; Fingerle V; Lobet Y; Gern L
    J Clin Microbiol; 2001 Mar; 39(3):1169-71. PubMed ID: 11230451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic variation and strain heterogeneity in Borrelia spp.
    Wilske B; Barbour AG; Bergström S; Burman N; Restrepo BI; Rosa PA; Schwan T; Soutschek E; Wallich R
    Res Microbiol; 1992; 143(6):583-96. PubMed ID: 1475519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
    Wressnigg N; Barrett PN; Pöllabauer EM; O'Rourke M; Portsmouth D; Schwendinger MG; Crowe BA; Livey I; Dvorak T; Schmitt B; Zeitlinger M; Kollaritsch H; Esen M; Kremsner PG; Jelinek T; Aschoff R; Weisser R; Naudts IF; Aichinger G
    Clin Vaccine Immunol; 2014 Nov; 21(11):1490-9. PubMed ID: 25185574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of lyme borreliosis patients.
    Floris R; Menardi G; Bressan R; Trevisan G; Ortenzio S; Rorai E; Cinco M
    New Microbiol; 2007 Oct; 30(4):399-410. PubMed ID: 18080675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis.
    Wang G; van Dam AP; Dankert J
    J Clin Microbiol; 1999 Sep; 37(9):3025-8. PubMed ID: 10449497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of outer surface proteins A and C by individual Borrelia burgdorferi in different genospecies.
    Fingerle V; Laux H; Munderloh UG; Schulte-Spechtel U; Wilske B
    Med Microbiol Immunol; 2000 Nov; 189(2):59-66. PubMed ID: 11138638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.
    Tilly K; Bestor A; Rosa PA
    Infect Immun; 2016 May; 84(5):1565-1573. PubMed ID: 26953324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Borrelia garinii isolated from Lyme disease patients in Hokkaido, Japan, by sequence analysis of OspA and OspB genes.
    Wang J; Masuzawa T; Yanagihara Y
    FEMS Microbiol Lett; 1997 Sep; 154(2):371-5. PubMed ID: 9311136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains.
    Wilske B; Luft B; Schubach WH; Zumstein G; Jauris S; Preac-Mursic V; Kramer MD
    Med Microbiol Immunol; 1992; 181(4):191-207. PubMed ID: 1279368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of Borrelia burgdorferi sensu lato species among patients in the Czech Republic; direct sequencing analysis and real-time polymerase chain reaction].
    Hulínská D; Drevová H; Votýpka J; Langrová K; Kurzová Z
    Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):183-91. PubMed ID: 15633539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lyme disease: pathogenesis and vaccine development.
    Simon MM; Bauer Y; Zhong W; Hofmann H; Wallich R
    Zentralbl Bakteriol; 1999 Dec; 289(5-7):690-5. PubMed ID: 10652726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
    Wieneke CA; Lovrich SD; Callister SM; Jobe DA; Marks JA; Schell RF
    J Clin Microbiol; 2000 Jan; 38(1):313-7. PubMed ID: 10618107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.